Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study.

Citrome L, Cucchiaro J, Sarma K, Phillips D, Silva R, Tsuchiya S, Loebel A.

Int Clin Psychopharmacol. 2012 May;27(3):165-76. doi: 10.1097/YIC.0b013e32835281ef.

PMID:
22395527
2.

Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial.

Nakamura M, Ogasa M, Guarino J, Phillips D, Severs J, Cucchiaro J, Loebel A.

J Clin Psychiatry. 2009 Jun;70(6):829-36. doi: 10.4088/JCP.08m04905.

PMID:
19497249
3.

Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study.

Ogasa M, Kimura T, Nakamura M, Guarino J.

Psychopharmacology (Berl). 2013 Feb;225(3):519-30. doi: 10.1007/s00213-012-2838-2.

4.

Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled study.

Nasrallah HA, Silva R, Phillips D, Cucchiaro J, Hsu J, Xu J, Loebel A.

J Psychiatr Res. 2013 May;47(5):670-7. doi: 10.1016/j.jpsychires.2013.01.020.

PMID:
23421963
5.
6.

Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: a 12-month, double-blind, noninferiority study.

Loebel A, Cucchiaro J, Xu J, Sarma K, Pikalov A, Kane JM.

Schizophr Res. 2013 Jun;147(1):95-102. doi: 10.1016/j.schres.2013.03.013.

7.

Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.

Citrome L.

Int J Clin Pract. 2011 Feb;65(2):189-210. doi: 10.1111/j.1742-1241.2010.02587.x. Review.

PMID:
21129135
8.

Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder.

Potkin SG, Ogasa M, Cucchiaro J, Loebel A.

Schizophr Res. 2011 Nov;132(2-3):101-7. doi: 10.1016/j.schres.2011.04.008.

PMID:
21889878
9.
10.

Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: a randomized, double-blind, placebo- and active-controlled trial.

Loebel A, Cucchiaro J, Sarma K, Xu L, Hsu C, Kalali AH, Pikalov A, Potkin SG.

Schizophr Res. 2013 Apr;145(1-3):101-9. doi: 10.1016/j.schres.2013.01.009.

11.

Lurasidone: a new treatment option for schizophrenia.

Owen RT.

Drugs Today (Barc). 2011 Nov;47(11):807-16. doi: 10.1358/dot.2011.47.11.1708832. Review.

PMID:
22146224
12.
13.

Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study.

Zhong KX, Sweitzer DE, Hamer RM, Lieberman JA.

J Clin Psychiatry. 2006 Jul;67(7):1093-103.

PMID:
16889453
14.

Lurasidone in schizophrenia: new information about dosage and place in therapy.

Citrome L.

Adv Ther. 2012 Oct;29(10):815-25. doi: 10.1007/s12325-012-0052-6. Review.

PMID:
23001538
15.

[Short-term efficacy and safety of lurasidone in the treatment of schizophrenia].

Samalin L, Ben Gharbia M, Garnier M, Llorca PM.

Encephale. 2014 Dec;40(6):507-17. Review. French.

PMID:
25453735
16.

Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study.

Meltzer HY, Cucchiaro J, Silva R, Ogasa M, Phillips D, Xu J, Kalali AH, Schweizer E, Pikalov A, Loebel A.

Am J Psychiatry. 2011 Sep;168(9):957-67. doi: 10.1176/appi.ajp.2011.10060907.

PMID:
21676992
17.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
18.

A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder.

Simpson GM, Mahmoud RA, Lasser RA, Kujawa M, Bossie CA, Turkoz I, Rodriguez S, Gharabawi GM.

J Clin Psychiatry. 2006 Aug;67(8):1194-203.

PMID:
16965196
19.

A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia.

Li H, Rui Q, Ning X, Xu H, Gu N.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):1002-8. doi: 10.1016/j.pnpbp.2011.02.001.

PMID:
21315787
20.

Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia.

Loebel AD, Siu CO, Cucchiaro JB, Pikalov AA, Harvey PD.

CNS Spectr. 2014 Apr;19(2):197-205. doi: 10.1017/S1092852913000904.

Items per page

Supplemental Content

Support Center